Tag:
Tuberculosis
Latest Headlines
Latest Headlines
TB vaccine in South African trials; blueprint will drive development
A new TB vaccine is expected to complete the first advanced clinical trials in South Africa in 2013.
Related bacterium could create viable TB vax
The current tuberculosis vaccine--bacille Calmette-Guérin (BCG)--has produced varying efficacy rates worldwide, ranging from 0% to 80%. In a new study published in Nature Medicine, however,
TB remedy could further the cancer fight
Scientists at St. George's, University of London, have found a way to assist the body's immune system against cancer using an old tuberculosis remedy. A vaccine created with the germ Baculillus
Aeras kicks off TB trial in HIV patients
In an effort to combat tuberculosis, Aeras and the Oxford-Emergent Tuberculosis Consortium have announced the start of a Phase IIb trial of the MVA85A vaccine. The 1,400-person proof-of-concept study
Study: Timing of new TB vaccine matters
A experimental vaccine for tuberculosis, called MVA85A, is more effective when give alone than in combination with other childhood shots. The next-generation vaccine is being developed by Emergent
Protein could lead to better TB vaccine
The current vaccine for tuberculosis uses a bovine version of the disease to protect humans who've contracted the illness. It provides some protection but is not entirely effective. However,
Sequella inks $50M Russian licensing pact for TB treatment
Rockville, MD-based Sequella has completed a round of high-fives with leaders of the region's biotech community after inking a licensing pact covering Russia and surrounding states for its mid-stage
Promising protein may yield TB vax
Researchers found hope in the quest for a new, more effective tuberculosis vaccine in the form of a protein. According to scientists in the UK, the EspC protein showed more promising results than the
Biotechs join forces in TB-fighting consortium
AstraZeneca became the newest member of a €16 million multi-member partnership to find new therapies for tuberculosis. The current remedies for the disease have been in use for over 50 years,
RecipharmCobra oral TB vax produces good immune response
Study results published in the journal Vaccine show that the orally delivered ORT-VAC DNA vaccine produced higher immune responses in mice than the injected DNA vaccine, according to RecipharmCobra
